HTX > Great Ann,...HealthLinx specialises in developing new...

HTX > Great Ann,...HealthLinx specialises in developing new generation diagnostic blood tests to detect cancers.

OvPlex, the Companys first product, has been released to the market.

OvPlex is an ovarian cancer diagnostic that has a diagnostic efficiency of 92% for early stage ovarian cancer.

This product is now available in Australia and in February 2010 the product will be launched in the UK and Ireland with other countries following over the next twelve months.

Could be a play TODAY!..Will be watching this closely..